Plant-made HIV vaccines and potential candidates

Jocelyne Trémouillaux-Guiller , Khaled Moustafa, Kathleen Hefferon, Goabaone Gaobotse, Makhzoum Abdullah

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)


Millions of people around the world suffer from heavy social and health burdens related to HIV/AIDS and its associated opportunistic infections. To reduce these burdens, preventive and therapeutic vaccines are required. Effective HIV vaccines have been under investigation for several decades using different animal models. Potential plant-made HIV vaccine candidates have also gained attention in the past few years. In addition to this, broadly neutralizing antibodies produced in plants which can target conserved viral epitopes and neutralize mutating HIV strains have been identified. Numerous epitopes of glycoproteins and capsid proteins of HIV-1 are a part of HIV therapy. Here, we discuss some recent findings aiming to produce anti-HIV-1 recombinant proteins in engineered plants for AIDS prophylactics and therapeutic treatments.
Original languageEnglish
Pages (from-to)209-216
JournalCurrent Opinion in Biotechnology
Publication statusPublished - 2020


Dive into the research topics of 'Plant-made HIV vaccines and potential candidates'. Together they form a unique fingerprint.

Cite this